A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01455909
Recruitment Status : Withdrawn
First Posted : October 20, 2011
Last Update Posted : December 25, 2012
Information provided by (Responsible Party):
Intarcia Therapeutics

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2014
  Estimated Study Completion Date : July 2014